Last updated on July 2018

High Cholesterol and Heart Disease -- SPIRE Program

Brief description of study

High Cholesterol and Heart Disease -- SPIRE Program

Detailed Study Description


The SPIRE program is a series of clinical studies that is investigating a study drug in people who have high cholesterol. This study drug is being evaluated to understand its effects on bad cholesterol (LDL-C) and cardiovascular events such as heart attack or stroke.

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-1) identifier: NCT01975376


Clinical Study Identifier: TX144222

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.